Parameters of drug antagonism: Re-examination of two modes of functional competitive drug antagonism on intraocular muscles

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 8, 2004, Pages 1045-1053

  Patil, Popat N ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CARBACHOL; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYCLOPENTOLATE; HEXAMETHONIUM; LIPID; METHYLATROPINE; NICOTINE TARTRATE; OXYBUTYNIN; PENTOBARBITAL; PHYSOSTIGMINE SALICYLATE; PIRENZEPINE; SCOPOLAMINE; TROPICAMIDE; TUBOCURARINE CHLORIDE; WATER;

ANIMAL TISSUE; ANOCOCCYGEUS MUSCLE; ARTICLE; BINDING AFFINITY; CILIARY MUSCLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; DRUG SOLUBILITY; FROG; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IC 50; IONIZATION; LIPID SOLUBILITY; MICROMORPHOLOGY; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PHYSICAL CHEMISTRY; PREDICTION; RAT; RECTUS ABDOMINIS MUSCLE; SPHINCTER PUPILLAE MUSCLE; THEORY; TISSUE DISTRIBUTION;

ABDOMINAL MUSCLES; ANIMALS; ATROPINE; CARBACHOL; CHOLINERGIC AGONISTS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; MUSCLE CONTRACTION; MUSCLE RELAXATION; OCULOMOTOR MUSCLES; PARASYMPATHOLYTICS; PHYSOSTIGMINE; RATS; XENOPUS LAEVIS;

EID: 4344652935     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357043978     Document Type: Article

References (39)

1. Ariëns, E. J. (1954) Affinity and intrinsic activity in the theory of competitive inhibition Part I. Problems and theory. Arch. Int. Pharmacodyn. 99: 32-49
2. Arunlakshana, O., Schild, H. O. (1959) Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14: 48-58
3. Barlow, R. B. (1995) Use of antagonist for estimating the degree of agonist stimulation during physiological release. Trends Pharmacol. Sci. 16: 262-264
4. Barlow, R. B., Chan, M. (1982) The effects of pH on the affinity of pirenzepine for muscarinic receptors in the guinea pig ileum and rat fundus strip. Br. J. Pharmacol. 77: 559-563
5. Bowman, W. C., Rand, M. J. (1980) Textbook of pharmacology. 2nd edn, Blackwell Scientific Publications, Oxford, pp. 39-41
6. 50 of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108
7. Colquhoun, D. (1998) Binding, gating, affinity and efficacy: the interpretation of structure activity relationships for agonists and effects of mutating receptors. Br. J. Pharmacol. 125: 923-947
8. Eglen, R. M., Whiting, R. L. (1989) Problems associated with the application of the Cheng-Prusoff relationship to estimate atropine affinity constants using functional tissue responses. Life Sci. 44: 81-94
9. 2-adrenoceptors. J. Pharm. Pharmacol. 40: 609-612
10. Foye, W. O., Lemke, T. L., Williams, D. A. (1995) Principles of medicinal chemistry. 4th edn, Williams and Wilkins, Baltimore
11. Furchgott, R. F. (1964) Receptor mechanisms. Ann. Rev. Pharmacol. 4: 21-50
12. Furchgott, R. F. (1967) The pharmacological differentiation of adrenergic receptors. Ann. NY Acad. Sci. 139: 553-570
13. Furchgott, R. F. (1972) The classification of adrenoceptors (adrenergic receptors): an evaluation from standpoint of receptor theory. In: Blaschko, H, Muscholl, E. (eds) Catecholamines. Handbook of experimental pharmacology, Vol XXXIII, Springer Verlag, New York, p. 283
14. Gaddum, J. H. (1937) The quantitative effects of antagonistic drugs. J. Physiol. (London): 7P-9P
15. Gaddum, J. H. (1957) Drug antagonism. Pharmacol. Rev. 9: 211-217
16. Gillespie, J. S. (1972) The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br. J. Pharmacol. 45: 404-416
17. Hansch, C. (Chair Ed. Board) (1990) Comprehensive medicinal chemistry. Vol 6, Pergamon Press, New York
18. Hansch, C., Leo, A. (1995) Exploring QSAR. American Chemical Society, Washington, DC, p. 97
19. Ishikawa, H., DeSantis, L., Patil, P. N. (1998) Selectivity of muscarinic agonists including (±)-aceclidine and antimuscarinics on the human intraocular muscles. J. Ocular Pharmacol. Ther. 14: 363-372
20. Itoh, T., Kuriyama, H. (1994) Excitation-contraction coupling mechanisms in visceral smooth muscle cells. In: Szekeres, L., Papp, J. (eds) Pharmacology of smooth muscle. Handbook of experimental pharmacology, Vol 111. Springer Verlag, New York, p. 57
21. Jarv, J., Hedlund, B., Barfai, T. (1980) Kinetic studies on muscarinic antagonist-agonist competition. J. Biol. Chem. 255: 2649-2651
22. Kenakin, T. P. (1993) Pharmacologic analysis of drug-receptor interaction. 2nd edn, Raven Press, New York
23. Kenakin, T. (2002) Drug efficacy at G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 42: 349-379
24. Lazareno, S., Birdsall, N. J. M. (1993) Estimation of competitive antagonist affinity from inhibition curves using the Gaddum, Schild and Cheng-Prusoff equation. Br. J. Pharmacol. 109: 1110-1119
25. Motulsky, H. J., Mahan, L. C. (1984) The kinetics of competitive radioligand binding predicted by the law of mass action. Mol. Pharmacol. 25: 1-9
26. Ostrum, R. S. (2002) New determinants of receptor-effector coupling: trafficking and compartmentation in membrane microdomains. Mol. Pharmacol. 61: 473-476
27. Patil, P. N. (1992) Reactivity of human iris sphincter to muscarinic drugs in vitro. Naunyn Schmiedebergs Arch. Pharmacol. 346:614-619
28. Patil, P. N. (1996) Pharmacologic quantitation. Indian J. Exp. Biol. 34: 615-633
29. Patil, P. N. (1999) Enhanced sensitivity of the iris sphincter to the muscarinic agonist carbachol at lower temperature. J. Ocular Pharmacol. Ther. 15: 65-72
30. Patil, P. N. (2001) Reversal of cholinergic response of intraocular muscles by atropine: drug antagonism re-examined. In: Gupta, S. K. (ed.) Pharmacology and therapeutics in the new millennium. Narosa Publishing House, New Delhi, p. 579
31. Patil, P. N. (2002) Two processes of competitive drug antagonism. XIV World Congress of Pharmacology Abstract, July 7-12, San Francisco, CA
32. Patil, P. N., Mauger, T. F. (1992) Cholinergic sensitivity of irides from donors with various pathological conditions and lens implants. Naunyn Schmiedebergs Arch. Pharmacol. 346: 620-628
33. Ritchie, J. M., Ritchie, B., Greengard, P. (1965) The active structure of local anesthetics. J. Pharmacol. Exp. Ther. 150: 152-159
34. Salazar, M., Shimada, K.,Patil, P. N. (1976) Iris pigmentation and atropine mydriasis. J. Pharmacol. Exp. Ther. 197: 79-88
35. Schild, H. O. (1947a) pA, a new scale for the measurement of drug antagonism. Br. J. Pharmacol. 2: 189-206
36. Schild, H. O. (1947b) The use of drug antagonist for the identification and classification of drugs. Br. J. Pharmacol. 2: 251-258
37. The Staff (1968) Department of Pharmacology, University of Edinburgh, Pharmacological experiments on isolated preparations. E & S Livingstone, Ltd, London
38. van Rossum, J. M., Van den Brink, F. G. (1963) Cumulative dose-response curves. I Introduction to the technique. Arch. Int. Pharmacodyn. Ther. 143: 240-246
39. Waud, D. R., Leeson, S., Waud, B. E. (1978) Kinetic and empirical analysis of dose-response curves illustrated with a cardiac example. Life Sci. 22: 1275-1286